1. Home
  2. BLRX vs CETY Comparison

BLRX vs CETY Comparison

Compare BLRX & CETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • CETY
  • Stock Information
  • Founded
  • BLRX 2003
  • CETY 1993
  • Country
  • BLRX Israel
  • CETY United States
  • Employees
  • BLRX N/A
  • CETY N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • CETY Power Generation
  • Sector
  • BLRX Health Care
  • CETY Utilities
  • Exchange
  • BLRX Nasdaq
  • CETY Nasdaq
  • Market Cap
  • BLRX 36.0M
  • CETY 41.0M
  • IPO Year
  • BLRX 2011
  • CETY N/A
  • Fundamental
  • Price
  • BLRX $0.48
  • CETY $0.71
  • Analyst Decision
  • BLRX Strong Buy
  • CETY
  • Analyst Count
  • BLRX 2
  • CETY 0
  • Target Price
  • BLRX $11.50
  • CETY N/A
  • AVG Volume (30 Days)
  • BLRX 407.5K
  • CETY 134.9K
  • Earning Date
  • BLRX 11-29-2024
  • CETY 11-26-2024
  • Dividend Yield
  • BLRX N/A
  • CETY N/A
  • EPS Growth
  • BLRX N/A
  • CETY N/A
  • EPS
  • BLRX N/A
  • CETY N/A
  • Revenue
  • BLRX $17,048,000.00
  • CETY $13,548,613.00
  • Revenue This Year
  • BLRX N/A
  • CETY N/A
  • Revenue Next Year
  • BLRX N/A
  • CETY N/A
  • P/E Ratio
  • BLRX N/A
  • CETY N/A
  • Revenue Growth
  • BLRX N/A
  • CETY 296.83
  • 52 Week Low
  • BLRX $0.39
  • CETY $0.45
  • 52 Week High
  • BLRX $1.93
  • CETY $2.39
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 53.32
  • CETY 40.18
  • Support Level
  • BLRX $0.40
  • CETY $0.61
  • Resistance Level
  • BLRX $0.46
  • CETY $1.27
  • Average True Range (ATR)
  • BLRX 0.03
  • CETY 0.09
  • MACD
  • BLRX 0.01
  • CETY -0.00
  • Stochastic Oscillator
  • BLRX 94.50
  • CETY 15.15

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business, as well as continuing to support other emerging growth companies with their Clean-tech technologies. It has four segments: Clean Energy HRS & CETY Europe, CETY HK, CETY Renewables and Electronic Manufacturing. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

Share on Social Networks: